SOLIS CLINICAL CONSULTING financials
A multi-period view of the public annual-account figures reported for SOLIS CLINICAL CONSULTING, with comparable measures and links to available source documents.
Company overviewRegistry number
0798666128
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 28, 2026
Financial evidence
Latest movements for SOLIS CLINICAL CONSULTING
2025 versus 2024
- Operating line
- €166,804
- EBITDA
- €166,199
- Total assets
- €462,828
- Equity
- €439,116
-32.6%
-32.7%
+43.4%
+40.1%
EBITDA margin +99.6% · Equity ratio +94.9%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202531 Dec 2025 | €166,804 | €166,199 | €462,828 | €439,116 | - |
| 202431 Dec 2024 | €247,315 | €246,937 | €322,777 | €313,349 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.